Browse Items · NEOMED Bibliography Database

Community-Acquired Pneumonia in Older Adults

Community-acquired pneumonia (CAP) is a common disorder with significant morbidity and mortality, particularly for older adults. Risk factors include comorbid conditions commonly found in older patients as well as immunocompromising conditions such…

Tags: 2015, antimicrobial therapy, Breen T R, Community-acquired pneumonia, Current Geriatrics Reports, Elderly, File T M, Geriatrics & Gerontology, Journal Article or Conference Abstract Publication, Nursing home-acquired pneumonia, Respiratory pathogens, Vaccine

IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults

Evidence-based guidelines for the diagnosis and initial management of suspected acute bacterial rhinosinusitis in adults and children were prepared by a multidisciplinary expert panel of the Infectious Diseases Society of America comprising…

Acute Bronchitis: An Indication For Antibiotic Avoidance

Tags: 1999, adults, care, Community-acquired pneumonia, Current opinion in infectious diseases, File T M, Infectious Diseases, Physicians, respiratory-tract infections, trends

Duration And Cessation Of Antimicrobial Treatment

Fluoroquinolones And Respiratory Tract Infections: Do They Work?

Tags: 1997, acute, antibacterial activity, antibiotic-therapy, chronic-bronchitis, Community-acquired pneumonia, exacerbations, File T M, Hospitalization, Immunology, in-vitro, Infectious Diseases, Infectious Diseases in Clinical Practice, obstructive pulmonary-disease, oral ciprofloxacin, requiring, streptococcus-pneumoniae

New Insights In The Treatment By Levofloxacin

Rational Use Of Antibiotics To Treat Respiratory Tract Infections

Tags: 2002, acute bronchitis, acute otitis-media, American Journal of Managed Care, Antimicrobial, Community-acquired pneumonia, File T M, General & Internal Medicine, group, Hadley J A, Health Care Sciences & Services, judicious use, obstructive, placebo-controlled trial, pulmonary-disease, resistance, resistant streptococcus-pneumoniae, therapeutic working, united-states

What Is Optimal Antimicrobial Therapy For Bacteremic Pneumococcal Pneumonia?

Tags: 2003, adults, Antigen, Clinical Infectious Diseases, Community-acquired pneumonia, elderly patients, File T M, Immunology, Infectious Diseases, Mandell L A, Microbiology, outcomes, urine samples

Clinical Implications Of 750mg, 5-day Levofloxacin For The Treatment Of Community Acquired Pneumonia

Streptococcus Pneumoniae: Resistance Patterns, Disease Trends, And Clinical Implications - Introduction

Tags: 2004, adults, American Journal of Medicine, Community-acquired pneumonia, File T M, General & Internal Medicine, guidelines, Management, Poole M D

The Clinical Relevance Of Penicillin-resistant Streptococcus Pneumoniae: A New Perspective

Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.

BACKGROUND: Therapy directed against atypical pathogens in patients with community-acquired pneumonia (CAP) is often recommended. This post-hoc analysis evaluated the effect of addition of a macrolide to ceftaroline fosamil or ceftriaxone treatment…

Tags: 2017, 80 and over, Adult, Aged, Anti-Bacterial Agents/adverse effects/*therapeutic use, Atypical pathogen, Bacterial/*drug therapy, Ceftaroline fosamil, Ceftriaxone/adverse effects/*therapeutic use, Cephalosporins/adverse effects/*therapeutic use, Chlamydial Pneumonia, Chlamydophila pneumoniae, Clinical Trials, Combination/adverse effects/methods, Community-Acquired Infections/*drug therapy, Community-acquired pneumonia, Department of Internal Medicine, Double-Blind Method, Drug Therapy, Eckburg Paul B, Female, File Thomas M Jr, Friedland H David, Humans, International journal of antimicrobial agents, Legionella pneumophila, Llorens Lily, Macrolide, Macrolides/adverse effects/*therapeutic use, Male, Middle Aged, Mycoplasma, Mycoplasma pneumoniae, NEOMED College of Medicine, Phase III as Topic, Pneumonia, Randomized Controlled Trials as Topic, Talbot George H, Time Factors, Treatment Outcome

Antimicrobial Treatment Of Lower Respiratory Tract Infections In The Hospital Setting

Respiratory tract infections (RTIs) that may require hospitalization include acute exacerbations of chronic bronchitis (AECB), community-acquired pneumonia (CAP), and hospital-acquired pneumonia (HAP), which includes ventilator-associated pneumonia…

Gemifloxacin Once Daily For 7 Days Compared To Amoxicillin/clavulanic Acid Thrice Daily For 10 Days For The Treatment Of Community-acquired Pneumonia Of Suspected Pneumococcal Origin

Context: Community-acquired pneumonia (CAP) is common among adults and contributes considerably to morbidity and mortality. Objective: To compare the safety and efficacy of gemifloxacin to high-dose amoxicillin/clavulanate for the treatment of CAP of…

Medication Options For The Treatment Of Cap

Tags: 2006, American family physician, Community-acquired pneumonia, efficacy, File T M, Gemifloxacin, General & Internal Medicine, Iannini P B, Mandell L A, Safety

Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza

Post-influenza bacterial pneumonia is a major cause of morbidity and mortality associated with both seasonal and pandemic influenza virus illness. However, despite much interest in influenza and its complications in recent years, good clinical trial…

Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae

Macrolide resistance among Streptococcus pneumoniae is a growing global concern, although its specific impact on public health is not currently well defined. A Consensus Working Group was convened in March 2001 to address whether credible, scientific…

Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia

We conducted a multicenter, retrospective cohort study of patients with Streptococcus pneumoniae bacteremia to determine factors associated with antibiotic resistance and mortality. Risk factors were identified using multivariate logistic regression.…

An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic

Omadacycline is a semisynthetic tetracycline antibiotic. Phase III clinical trial results have shown that omadacycline has an acceptable safety profile in the treatment of acute bacterial skin and skin structure infections and community-acquired…

Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA

Objective: To compare demographic and clinical characteristics, and methicillin-resistant Staphylococcus aureus (MRSA) strain characteristics, in patients with early-onset (EO) and late-onset (LO) MRSA nosocomial pneumonia. Methods: This was a…

Treatment of community-acquired pneumonia in immunocompromised adults: A consensus statement regarding initial strategies

Background Community-acquired pneumonia (CAP) guidelines have improved the treatment and outcomes of patients with CAP, primarily by standardization of initial empirical therapy. But current society-published guidelines exclude immunocompromised…

Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults

Pneumococcal disease, which includes pneumococcal pneumonia, meningitis, and bacteremia, is associated with substantial morbidity, mortality, and health care costs in adults. Advanced age, chronic lung or cardiovascular disease, immunosuppressive…

How long should we treat community-acquired pneumonia?

Purpose of review: The studies, reviewed in this article suggest that a shorter duration of antibiotic therapy is comparable to standard therapy in the treatment of community-acquired pneumonia and promotes reduction of adverse events, microbial…

Tags: 2007, antibacterial response, antibiotic-therapy, antimicrobial therapy, azithromycin, clinical-efficacy, Community-acquired pneumonia, Current opinion in infectious diseases, double-blind, duration of therapy, File T M, Infectious Diseases, Journal Article, Practice Guidelines, respiratory-tract infections, Scalera N M, short-duration therapy, Streptococcus pneumoniae

Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremia

The Streptococcus pneumoniae (SP) urinary antigen (UAg) test is a commonly used assay. The purpose cif this study was to evaluate the test's actual performance in the clinical setting and determine the effects of renal function, grade of bacteremia,…

Managing patients with recurrent acute exacerbations of chronic bronchitis: a common clinical problem

Chronic obstructive pulmonary disease (COPD) affects 15 million people and is the fourth leading cause of death in the United States. It places a considerable burden on the healthcare system, with exacerbations contributing to a significant…

Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged >= 50 Years With Community-Acquired Pneumonia

Background. Streptococcus pneumoniae causes a substantial proportion of community-acquired pneumonia (CAP) and healthcare-associated pneumonia (HCAP) in the United States. Limited data are available regarding the pneumococcal serotypes causing CAP…

A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria

In response to the overuse and misuse of antibiotics, leading to increasing bacterial resistance and decreasing development of new antibiotics, the Council for Appropriate and Rational Antibiotic Therapy (CARAT) has developed criteria to guide…

Risk factors for domestic acquisition of Legionnaires disease

Background: Legionnaires disease is a common cause of adult pneumonia. Outbreaks of legionnaires disease have been well described, but little is known about sporadically occurring legionnaires disease, which accounts for most infections. Exposure to…

Legionnaires disease with bacteremic coinfection

We describe 6 patients who had bacteremic community-acquired pneumonia and unsuspected Legionella pneumophila coinfection. We reviewed case records of patients who were diagnosed as having a recent Legionella infection on the basis of either the…

Tags: 2002, adults, Clinical Infectious Diseases, Community-acquired pneumonia, criteria, File T M, Immunology, Infection, Infectious Diseases, Influenza, Journal Article, legionella-pneumophila, measles, Microbiology, risk-factors, surveillance, Tan J S, Tan M J

Respiratory infections unique to Asia

Asia is a highly heterogeneous region with vastly different cultures, social constitutions and populations affected by a wide spectrum of respiratory diseases caused by tropical pathogens. Asian patients with community-acquired pneumonia differ from…

Browse Items (30 total)